Your account is not claimed yet. You can sign up with ORCID to claim your account.

Zhenhua Shao

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 18

Top Venues

Nature communications

Cell research

Nature chemical biology

Signal transduction and targeted therapy

Sichuan University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sichuan University May 1o 2018

China

Professor :: State Key Laboratory of Biotherapy

Publications

Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Yanping Qian, Zhenhua Shao
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature communications 14 (1) (2023)
Zheng Xu, Lulu Guo, Jingjing Yu, Siyuan Shen, Chao Wu, Weifeng Zhang, Chang Zhao, Yue Deng, Xiaowen Tian, Yuying Feng, Hanlin Hou, Lantian Su, Hongshuang Wang, Shuo Guo, Heli Wang, Kexin Wang, Peipei Chen, Jie Zhao, Xiaoyu Zhang, Xihao Yong, Lin Cheng, Lunxu Liu, Sheng-Yong Yang, Fan Yang, Xiaohui Wang, Xiao Yu, Yun-Fei Xu, Jin-Peng Sun, Wei Yan, Zhenhua Shao
Ligand recognition and G protein coupling of trace amine receptor TAAR1. Nature (2023)
Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Yanping Qian, Zhenhua Shao
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature communications 14 (1) (2023)
Yuying Feng, Chang Zhao, Yue Deng, Heli Wang, Liang Ma, Sicen Liu, Xiaowen Tian, Bo Wang, Yan Bin, Peipei Chen, Wei Yan, Ping Fu, Zhenhua Shao
Mechanism of activation and biased signaling in complement receptor C5aR1. Cell research (2023)
Yuying Feng, Chang Zhao, Yue Deng, Heli Wang, Liang Ma, Sicen Liu, Xiaowen Tian, Bo Wang, Yan Bin, Peipei Chen, Wei Yan, Ping Fu, Zhenhua Shao
Mechanism of activation and biased signaling in complement receptor C5aR1. Cell research (2023)
Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Yanping Qian, Zhenhua Shao
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature communications 14 (1) (2023)
Lin Cheng, Suyue Sun, Heli Wang, Chang Zhao, Xiaowen Tian, Ying Liu, Ping Fu, Zhenhua Shao, Ren-Jie Chai, Wei Yan
Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2. Signal transduction and targeted therapy 8 (1) (2023)
An-Jie Xia, Xihao Yong, Changbin Zhang, Guifeng Lin, Guowen Jia, Chang Zhao, Xin Wang, Yize Hao, Yifei Wang, Pei Zhou, Xin Yang, Yue Deng, Chao Wu, Yujiao Chen, Jiawei Zhu, Xiaodi Tang, Jingming Liu, Shiyu Zhang, Jiahao Zhang, Zheng Xu, Qian Hu, Jinlong Zhao, Yuting Yue, Wei Yan, Zhaoming Su, Yuquan Wei, Rongbin Zhou, Haohao Dong, Zhenhua Shao, Shengyong Yang
Cryo-EM structures of human GPR34 enable the identification of selective antagonists. Proceedings of the National Academy of Sciences of the United States of America 120 (39) (2023)
Xiao Teng, Sijia Chen, Yingying Nie, Peng Xiao, Xiao Yu, Zhenhua Shao, Sanduo Zheng
Ligand recognition and biased agonism of the D1 dopamine receptor. Nature communications 13 (1) (2022)
Zheng Xu, Zhenhua Shao
Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug. Signal transduction and targeted therapy 7 (1) (2022)
Wei Yang, Bo Mu, Jing You, Chenyu Tian, Huachao Bin, Zhiqiang Xu, Liting Zhang, Ronggang Ma, Ming Wu, Guo Zhang, Chong Huang, Linli Li, Zhenhua Shao, Lunzhi Dai, Laurent Désaubry, Sheng-Yong Yang
Non-classical ferroptosis inhibition by a small molecule targeting PHB2. Nature communications 13 (1) (2022)
Xin Yang, Xuehui Wang, Zheng Xu, Chao Wu, Yangli Zhou, Yi-Fei Wang, Guifeng Lin, Kan Li, Ming Wu, An-Jie Xia, Jingming Liu, Lin Cheng, Jun Zou, Wei Yan, Zhenhua Shao, Sheng-Yong Yang
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1. Nature chemical biology 18 (8) (2022)
Jiao Qin, Ye Cai, Zheng Xu, Qianqian Ming, Su-Yu Ji, Chao Wu, Huibing Zhang, Chunyou Mao, Dan-Dan Shen, Kunio Hirata, Yanbin Ma, Wei Yan, Yan Zhang, Zhenhua Shao
Molecular mechanism of agonism and inverse agonism in ghrelin receptor. Nature communications 13 (1) (2022)
Lin Cheng, Zhenhua Shao
Lighting up cholecystokinin. Nature chemical biology 17 (12) (2021)
Yuan Yuan, Guowen Jia, Chao Wu, Wei Wang, Lin Cheng, Qian Li, Ziyan Li, Kaidong Luo, Shengyong Yang, Wei Yan, Zhaoming Su, Zhenhua Shao
Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition. Cell research 31 (12) (2021)
Chang Zhao, Lin Cheng, Wei Wang, Heli Wang, Yongbo Luo, Yuying Feng, Xuehui Wang, Hong Fu, Ye Cai, Shengyong Yang, Ping Fu, Wei Yan, Zhenhua Shao
Structural insights into sphingosine-1-phosphate recognition and ligand selectivity of S1PR3-Gi signaling complexes. Cell research (2021)
Wei Yan, Lin Cheng, Wei Wang, Chao Wu, Xin Yang, Xiaozhe Du, Liang Ma, Shiqian Qi, Yuquan Wei, Zhi-Liang Lu, Shengyong Yang, Zhenhua Shao
Structure of the human gonadotropin-releasing hormone receptor GnRH1R reveals an unusual ligand binding mode. Nature communications 11 (1) (2020)
Zhenhua Shao, Wei Yan, Karen Chapman, Karthik Ramesh, Aaron J Ferrell, Jie Yin, Xuehui Wang, Qingping Xu, Daniel M Rosenbaum
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor. Nature chemical biology 15 (12) (2019)

Zhenhua Shao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhenhua Shao